Genoa Ventures
Venture capitalSan Francisco · Pre-Seed–Series A · 7 people tracked
Also known as GENOA VENTURES, LLC
Investment thesis
Genoa Ventures invests at the intersection of biology and technology, where it believes the convergence of these fields creates significant opportunity to accelerate innovation across industries. The firm seeks to identify these opportunities early and applies both capital and domain expertise to support emerging, category-defining companies. Its stated goal is to empower startups building toward a healthier, cleaner, and more productive world.
Source: firm website, verified Aug 7, 2026.
Team · 7 people
from public directories
What they invest in
from 18 of 25 portfolio companiesBiotech ×11Medical Devices ×9Healthtech ×6AgTech ×4AI & Machine Learning ×4Deep Tech ×4Digital Health ×2FoodTech ×2
HQs:United States×11United Kingdom×1
Investments · 25 tracked
founders shown can be your intro pathBrightSpec develops spectraMRR, a molecular rotational resonance spectroscopy platform for rapid identification and quantitation of molecules in complex mixtures.
BiotechDeep TechMedical DevicesWaltham, US
Rick Gordon(CEO)inTimothy Germann(Director)David Cash(Director)inWalter Colsman(Executive Officer, Director)JAFFRAY WOODRIFF(Director)ROBERT LLOYD(Executive Officer, Director)
Board seatJenny Rooke· per SEC Form D
Alpharetta, US
Rikki Jack(Indirect Manager)Douglas R. Kenny(Indirect Manager)Rick A. Kenny(Indirect Manager)Arabella FCRE Management, LLC(Manager)Richard Kenny(Indirect Manager)
Board seatRichard Kenny· per SEC Form D · $6M raise · filed Mar 2024
Alpharetta, US
Richard Kenny(Indirect Manager)Douglas R Kenny(Indirect Manager)Rick A. Kenny(Indirect Manager)FCRE SOTO Management, LLC(Manager)Rikki Jack(Indirect Manager)
Board seatRichard Kenny· per SEC Form D · $3.1M raise · filed Mar 2024
BiotechPortola Valley, US
Lena Wu(Executive Officer, Director)Erik Gentalen(Director)Michael Rubin(Director)Jenny Rooke(Director)
Board seatJenny Rooke· per SEC Form D · $3.2M raise · filed Nov 2018
BiotechRedwood City, US
Aldo Carrascoso(Executive Officer, Director)Adam D'Augelli(Director)Klaus Lindpaintner(Director)
Board seatJenny Rooke· per SEC Form D · $201.3M raise · filed Aug 2021
BRAINBox Solutions develops a diagnostic and prognostic platform for mild traumatic brain injury that combines blood biomarker panels, neurocognitive testing, and AI-driven scoring to provide objective evidence of injury and predict post-injury symptoms.
AI & Machine LearningBiotechHealthtechMedical DevicesHouston, US
Robert Sledd(Director)Marc Goldberg(Director)Donna Edmonds(Executive Officer, Director)Steve Wallace(Executive Officer)Scott Gazelle(Director)Vikram Chaudhery(Director)
Codetta Bio develops the Concerto System, a biomarker detection platform that combines digital PCR, qPCR, and immunoPCR technology to simultaneously measure proteins, DNA, and RNA from a single sample for multi-omics applications.
BiotechDeep TechMedical Devices
J. Michael Ramsey(Director)Jacques Corriveau(Executive Officer, Director)William Hampton Henley(Executive Officer)
BoardJohn Ho(Director)
Epitel develops REMI, a wireless EEG monitoring system with AI-powered seizure detection for use in healthcare facilities and ambulatory settings.
AI & Machine LearningHealthtechMedical DevicesSalt Lake City, US
New Culture produces animal-free dairy cheese products, starting with mozzarella for pizzerias, using food science to replicate the taste, melt, and stretch of conventional cheese.
Climate TechFoodTech
Redux Bio develops RNAi-based preventative disease management products for livestock and aquaculture farmers as sustainable alternatives to antibiotics.
AgTechBiotechHealthtech
Simbiosys develops AI-powered 3D visualization and diagnostic technology that converts 2D medical imaging into interactive 3D digital tumor models to support surgical planning and patient treatment.
AI & Machine LearningBiotechDigital HealthMedical DevicesChicago, US
Joseph Peterson(Executive Officer, Director)Stacey Stevens(Executive Officer, Director)John A Cole(Executive Officer)
BoardVikram Chaudhery(Director)Lucy Coassin(Director)Ronnie Andrews(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does Genoa Ventures invest at?
- Genoa Ventures invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Genoa Ventures focus on?
- Genoa Ventures focuses on AI & Machine Learning, Biotech, Cleantech, Deep Tech, Healthtech.
- Where is Genoa Ventures located?
- Genoa Ventures is headquartered in San Francisco, US.
- Does Genoa Ventures lead rounds?
- Genoa Ventures typically participates in rounds rather than leading them.
Images
Co-investors · 13
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
True Ventures is an early-stage venture capital firm that writes the first check for founders and supports them through subsequent stages of growth.
Amplify Partners is an early-stage venture firm that has invested in technical founders — engineers, researchers, and scientists — building applications, AI models, developer tools, and infrastructure since 2012.
Anzu Partners is an investment firm backing breakthrough clean tech, industrial, and life science technologies, supported by a team of investors, operators, consultants, scientists, and engineers who work alongside founders.
Tekfen Ventures is an early-stage venture capital firm headquartered in New York City that backs founders working on transformative technologies for legacy industries in construction, agriculture, and supply.
.png){kind=avatar}
Fuel Capital is an early-stage venture firm focused on backing outstanding founding teams across consumer technology, hardware, education, marketplaces, and retail.
.jpeg)
Heavybit provides hands-on, strategic support to startups building developer-focused and developer tool companies, offering guidance from its partners, platform, and community of advisors.
Vertex Ventures Southeast Asia & India is an early-stage, sector-agnostic venture capital firm investing in startups across Southeast Asia and India, providing capital alongside operational support such as hiring, go-to-market strategy and networking.
Prelude Ventures is a venture capital firm that invests in and supports early-stage startups with the potential to mitigate climate change.
Northpond Ventures is a science- and technology-driven investment firm that backs breakthrough businesses aiming to have a significant impact on humanity.
Samsara BioCapital is an investment firm backing the development of transformative therapeutics for patients, bringing together scientists, physicians, drug developers, and business leaders to support next-generation therapeutic breakthroughs.
Illumina Ventures is a venture investor focused on genomics and precision health, aiming to advance innovation and impact in human health.
▶1 more co-investors
Firms observed investing alongside Genoa Ventures, from public investor directories. Shared companies are the overlap with Genoa Ventures's recorded portfolio.
Similar investors
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
Khosla Ventures is a venture capital firm known for backing bold, contrarian bets in world-class teams that can reshape entire industries.
Good Growth Capital is a venture capital firm based in Charleston, SC, focused on early-stage science and technology startups, often spun out of university research labs.
EMV Capital is a venture capital investor that backs, strengthens, and manages early-stage companies with strong intellectual property across high-growth, high-impact technology sectors.